Quality of Recovery of Remimazolam Versus Sevoflurane in Transurethral Bladder Resection.
Status:
Not yet recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
This study was designated to investigate the quality of recovery after transurethral bladder
resection. Because, patients undergoing transurethral bladder resection are mostly old age,
and because of catheter-related bladder discomfort are common after transurethral bladder
resection, study on the quality of recovery after transurethral bladder resection seems to be
meaningful. In general, sevoflurane is commonly used as an anesthetic agent for general
anesthesia of transurethral bladder resection. The purpose of this study is to investigate
whether remimazolam is not inferior to sevoflurnane in terms of quality of recovery after
transurethral bladder resection.